Atara Biotherapeutics (ATRA) Metrics: History & Chart

Atara Biotherapeutics, Inc.(ATRA)

Biotechnology · Thousand Oaks, CA

$9.31-0.09 (-1.00%)

Delayed quote: Oct 6, 2026, 2:49 PM EDT

About Atara Biotherapeutics, Inc.

Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3 clinical trials for Epstein-Barr virus (EBV)-driven post-transplant lymphoproliferative disease, as well as various hematologic and solid tumors, such as nasopharyngeal carcinoma. The company is also advancing a robust pipeline of next-generation CAR T immunotherapies designed to combat hematologic malignancies and solid tumors. This includes ATA2271 and ATA3271 targeting mesothelin, alongside ATA2431 and ATA3219 for B-cell malignancies. Furthermore, Atara is developing ATA188 for the treatment of multiple sclerosis and the ATA368 program specifically for cancers associated with human papillomavirus (HPV). To bolster its research and development efforts, Atara Biotherapeutics has established significant collaborations and licensing agreements. These include a licensing partnership with Memorial Sloan Kettering Cancer Center, a license and R&D collaboration with QIMR Berghofer Medical Research Institute, and a strategic alliance with H. Lee Moffitt Cancer Center. Additionally, the company holds a strategic partnership with Bayer AG focused on mesothelin-targeted CAR T-cell therapies for solid tumors.

Thousand Oaks, CA

10 employees

www.atarabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Anhco Nguyen

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+12.31%
30D Total Return	-3.69%
YTD Total Return	-48.04%
1Y Total Return	-34.77%
3Y Total Return	-73.14%
5Y Total Return	-97.85%
10Y Total Return	-97.97%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-48.04%
2025	+35.91%
2024	+3.82%
2023	-84.37%
2022	-79.19%
2021	-19.71%
2020

CAGR TTM	-34.63%
CAGR 3Y	-35.47%
CAGR 5Y	-53.60%
CAGR 10Y	-32.27%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	3.14
PE Ratio Avg TTM	3.67
PE Ratio Avg 3Y	3.67
Current VS TTM Avg	-14.33%
Current VS 3Y Avg	-14.33%
Current VS 5Y Avg	-14.33%

All Metrics

ATRA Valuation Metrics

ATRA Stock Price Metrics

ATRA Dividend Metrics

ATRA Growth Rate Metrics

ATRA Discounted Cash Flow Metrics

ATRA Returns By Period

ATRA Yearly Returns

ATRA Average Annual Returns By Period (CAGR)

ATRA Revenue Metrics

ATRA PE Ratio Metrics

ATRA PS Ratio Metrics

ATRA PB Ratio Metrics

ATRA Price to Free Cash Flow Ratio Metrics

ATRA Debt to Equity Ratio Metrics

ATRA PEG Ratio Metrics

ATRA FCF Yield

ATRA Earnings Yield

ATRA EBITDA Yield

ATRA OCF Yield

ATRA EV/EBIT Ratio Metrics

ATRA EV/EBITDA Ratio Metrics

ATRA EV/Assets Ratio Metrics

ATRA EV/Sales Ratio Metrics

ATRA Current Ratio Metrics

ATRA Quick Ratio Metrics

ATRA ROIC Metrics

ATRA Return on Assets Metrics

ATRA Return on Equity Metrics

ATRA Net Profit Margin Metrics

ATRA Gross Profit Margin Metrics

ATRA Tax Rate Metrics

PS Ratio	22.81
PS Ratio Avg TTM	2.28
PS Ratio Avg 3Y	2.79
Current VS TTM Avg	+899.84%
Current VS 3Y Avg	+718.48%
Current VS 5Y Avg	+200.64%

PB Ratio	17.77
PB Ratio Avg TTM	2.66
PB Ratio Avg 3Y	3.24
Current VS TTM Avg	+567.50%
Current VS 3Y Avg	+448.98%
Current VS 5Y Avg	+458.87%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(0.27)
Debt/Equity Ratio Avg TTM	(0.80)
Debt/Equity Ratio Avg 3Y	(0.49)
Current VS TTM Avg	+66.73%
Current VS 3Y Avg	+45.52%
Current VS 5Y Avg	-7.56%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	31.80%
Earnings Yield Avg TTM	39.78%
Earnings Yield Avg 3Y	39.78%
Current VS TTM Avg	-20.06%
Current VS 3Y Avg	-20.06%
Current VS 5Y Avg	-20.06%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	4.71
Ev/Ebit Ratio Avg TTM	10.94
Ev/Ebit Ratio Avg 3Y	10.94
Current VS TTM Avg	-56.96%
Current VS 3Y Avg	-56.96%
Current VS 5Y Avg	-56.96%

Ev/Ebitda Ratio	4.45
Ev/Ebitda Ratio Avg TTM	8.06
Ev/Ebitda Ratio Avg 3Y	8.06
Current VS TTM Avg	-44.81%
Current VS 3Y Avg	-44.81%
Current VS 5Y Avg	-44.81%

Ev/Assets Ratio	7.04
Ev/Assets Ratio Avg TTM	6.21
Ev/Assets Ratio Avg 3Y	2.75
Current VS TTM Avg	+13.37%
Current VS 3Y Avg	+156.26%
Current VS 5Y Avg	+265.07%

Ev/Sales Ratio	23.89
Ev/Sales Ratio Avg TTM	2.51
Ev/Sales Ratio Avg 3Y	3.30
Current VS TTM Avg	+852.89%
Current VS 3Y Avg	+623.80%
Current VS 5Y Avg	+211.42%

Current Ratio	1.98
Current Ratio Avg TTM	1.53
Current Ratio Avg 3Y	1.14
Current VS TTM Avg	+28.77%
Current VS 3Y Avg	+72.99%
Current VS 5Y Avg	-10.81%

Quick Ratio	1.98
Quick Ratio Avg TTM	1.53
Quick Ratio Avg 3Y	1.09
Current VS TTM Avg	+28.77%
Current VS 3Y Avg	+80.80%
Current VS 5Y Avg	-9.37%

ROIC	(100.35%)
ROIC Avg 3Y	(257.73%)
ROIC Avg 5Y	(97.42%)
Current VS 3Y Avg	+61.07%
Current VS 5Y Avg	-3.00%
Current VS 10Y Avg	-31.11%

ROA	(79.38%)
ROA Avg TTM	(13.67%)
ROA Avg 3Y	(18.46%)
Current VS TTM Avg	-480.70%
Current VS 3Y Avg	-330.08%
Current VS 5Y Avg	-306.06%

ROE	N/A
ROE Avg TTM	(179.08%)
ROE Avg 3Y	(124.26%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(269.42%)
Net Profit Margin Avg TTM	(379.03%)
Net Profit Margin Avg 3Y	(323.09%)
Current VS TTM Avg	+28.92%
Current VS 3Y Avg	+16.61%
Current VS 5Y Avg	+67.35%

Gross Profit Margin	82.44%
Gross Pft Margin Avg TTM	86.53%
Gross Pft Margin Avg 3Y	84.88%
Current VS TTM Avg	-4.73%
Current VS 3Y Avg	-2.87%
Current VS 5Y Avg	+6.85%

Tax Rate	0.13%
Tax Rate Avg 3Y	0.04%
Tax Rate Avg 5Y	0.04%
Current VS 3Y Avg	+200.00%
Current VS 5Y Avg	+200.00%
Current VS 10Y Avg	+200.00%